The Madras Diabetes Research Foundation (MDRF), Chennai, has entered into a strategic collaboration with Premas Life Sciences to strengthen genomics and multi-omics research capabilities in India, with a particular focus on diabetes and metabolic disorders. The partnership is expected to support deeper scientific discovery, improve translational research and accelerate innovation in precision medicine.
Under the collaboration, MDRF will use advanced sequencing technologies along with Premas Life Sciences’ implementation and support expertise to enhance its research workflows. The two organisations said the effort will help build high-quality genomics systems and create integrated datasets by combining genomics with other omics approaches, enabling more comprehensive insights into chronic diseases.
A key part of the agreement is the collaborative development of research workflows, assays and applications tailored to India’s disease burden, especially diabetes and related metabolic conditions. The partnership also includes training and skilling initiatives such as workshops, hands-on sessions and knowledge-sharing programmes for researchers, clinicians and students, with a focus on next-generation sequencing technologies and data interpretation.
The memorandum of understanding also provides for Premas to support and facilitate strategic industry-academia partnerships for MDRF with relevant collaborators. In addition, the two institutions will work together on scientific outreach and awareness initiatives to promote the adoption of genomics in research and healthcare.
“At MDRF, we are committed to integrating cutting-edge technologies with clinical research to understand better and manage complex diseases such as diabetes,” said Dr. V. Mohan, Chairman, MDRF. Dr. Radha Venkatesan, Head of Genomics at MDRF, said the collaboration marks an important step in advancing genomics-driven research in India. Dr. R. M. Anjana, President of MDRF, said the partnership with Premas Life Sciences is aimed at creating solutions that are relevant to the Indian population.
Mr. Praveen Gupta, Managing Director, Premas Life Sciences, said the company’s focus has been to enable access to advanced genomics technologies and build strong scientific ecosystems in India. He said the collaboration reflects a shared vision of driving innovation through multi-omics, collaborative development and continuous skilling of the research community.
MDRF and Premas Life Sciences said they will continue to work with academic institutions, healthcare providers and researchers to strengthen the adoption of genomics and multi-omics approaches across the country.
Founded in Chennai, MDRF is a research institution focused on diabetes and related metabolic disorders, with an emphasis on translational research and improving patient care through scientific innovation. Premas Life Sciences provides solutions in genomics, proteomics and multi-omics, and works with global technology partners to help researchers and clinicians access advanced tools and technical support.
